Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Feucht

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Nature Cancer|April 27, 2023
LINKing signaling domains to enhance CAR T cellsPhilip Bucher, Judith Feucht
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 26, 2020
Senolytic CAR T Cells in Solid Tumors and Age-Related PathologiesJudith Feucht, Mohamed Abou-El-Enein
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 24, 2012
Induction of Thelper1-driven antiviral T-cell lines for adoptive immunotherapy is determined by differential expression of IFN-γ and T-cell activation markersJosef Leibold, Judith Feucht, Ameli Halder, et al.
Deutsche Medizinische Wochenschrift (1946)|June 30, 2012
[42-year-old patient with portal hypertension - case 6/2012]Josef Leibold, Serkan Karakaya, Birgit Federmann, et al.
Cancers|July 27, 2024
The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor ImmunityNgoc Thien Thu Nguyen, Rasmus Müller, Daria Briukhovetska, et al.
BMC Cancer|November 16, 2019
Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy - results of a non-interventional observation studySemjon Willier, Karin Melanie Cabanillas Stanchi, Martina von Have, et al.
Immunology|May 3, 2017
Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotypeNatascha Köstlin, Margit Vogelmann, Bärbel Spring, et al.
BMC Cancer|August 29, 2015
Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantationMichaela Döring, Karin Melanie Cabanillas Stanchi, Markus Mezger, et al.
Nature Medicine|January 30, 2019
Publisher Correction: Calibration of CAR activation potential directs alternative T cell fates and therapeutic potencyJudith Feucht, Jie Sun, Justin Eyquem, et al.
Annals of Hematology|November 28, 2015
Ferritin as an early marker of graft rejection after allogeneic hematopoietic stem cell transplantation in pediatric patientsMichaela Döring, Karin Melanie Cabanillas Stanchi, Judith Feucht, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Nature Cancer|April 27, 2023
LINKing signaling domains to enhance CAR T cellsPhilip Bucher, Judith Feucht
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 26, 2020
Senolytic CAR T Cells in Solid Tumors and Age-Related PathologiesJudith Feucht, Mohamed Abou-El-Enein
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 24, 2012
Induction of Thelper1-driven antiviral T-cell lines for adoptive immunotherapy is determined by differential expression of IFN-γ and T-cell activation markersJosef Leibold, Judith Feucht, Ameli Halder, et al.
Deutsche Medizinische Wochenschrift (1946)|June 30, 2012
[42-year-old patient with portal hypertension - case 6/2012]Josef Leibold, Serkan Karakaya, Birgit Federmann, et al.
Cancers|July 27, 2024
The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor ImmunityNgoc Thien Thu Nguyen, Rasmus Müller, Daria Briukhovetska, et al.
BMC Cancer|November 16, 2019
Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy - results of a non-interventional observation studySemjon Willier, Karin Melanie Cabanillas Stanchi, Martina von Have, et al.
Immunology|May 3, 2017
Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotypeNatascha Köstlin, Margit Vogelmann, Bärbel Spring, et al.
BMC Cancer|August 29, 2015
Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantationMichaela Döring, Karin Melanie Cabanillas Stanchi, Markus Mezger, et al.
Nature Medicine|January 30, 2019
Publisher Correction: Calibration of CAR activation potential directs alternative T cell fates and therapeutic potencyJudith Feucht, Jie Sun, Justin Eyquem, et al.
Annals of Hematology|November 28, 2015
Ferritin as an early marker of graft rejection after allogeneic hematopoietic stem cell transplantation in pediatric patientsMichaela Döring, Karin Melanie Cabanillas Stanchi, Judith Feucht, et al.
Pageof 5